Omega Fund IV, L.P.
Related Filers (22)
- Omega Fund IV GP, L.P. (25)
- Stampacchia Otello (25)
- Omega Fund IV G.P. Manager, Ltd. (25)
- Replimune Group, Inc. (25)
- Paster Anne-Mari (9)
- Lim Richard J. (7)
- Egalet Corp (5)
- ESSA Pharma Inc. (5)
- Translate Bio, Inc. (4)
- Danish Biotech SPV I P/S (2)
- Paratek Pharmaceuticals, Inc. (2)
- Omega Fund III, L.P. (2)
- Kezar Life Sciences, Inc. (2)
- Omega Fund V GP, L.P. (2)
- Omega Fund V, L.P. (2)
- Nessi Claudio (2)
- Omega Fund V GP Manager, Ltd. (2)
- Omega Fund III G.P., Ltd. (1)
- Omega Fund III GP, L.P. (1)
- Omega Fund Management LTD (1)
- Sigma Holding LTD (1)
- ALPINE IMMUNE SCIENCES, INC. (1)
- Show More ...
Other (3)
D/A
Friday, 5/24/2013
Exempt (Private) Offering
D/A
Friday, 5/24/2013
Exempt (Private) Offering
D
Thursday, 8/25/2011
Exempt (Private) Offering
Ownership (44)
SC 13G/A
Wednesday, 2/14/2024
Replimune Group, Inc.: Major Shareholders
SC 13G/A
Monday, 2/13/2023
Replimune Group, Inc.: Major Shareholders
4
Wednesday, 3/16/2022
Replimune Group, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Monday, 2/14/2022
Replimune Group, Inc.: Major Shareholders
4
Tuesday, 11/23/2021
Replimune Group, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 11/18/2021
Replimune Group, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 11/18/2021
Replimune Group, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/16/2021
Replimune Group, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 11/12/2021
Replimune Group, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/10/2021
Replimune Group, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 11/8/2021
Replimune Group, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 9/27/2021
Replimune Group, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 9/20/2021
Replimune Group, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 4/5/2021
Replimune Group, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Friday, 2/12/2021
ESSA Pharma Inc.: Major Shareholders
4
Thursday, 2/11/2021
Replimune Group, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/28/2021
Replimune Group, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/26/2021
Replimune Group, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/19/2021
Replimune Group, Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Thursday, 8/6/2020
ALPINE IMMUNE SCIENCES, INC.: Major Shareholders
4
Friday, 4/3/2020
Replimune Group, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Friday, 2/14/2020
Replimune Group, Inc.: Major Shareholders
SC 13G/A
Friday, 2/14/2020
Translate Bio, Inc.: Major Shareholders
SC 13G/A
Friday, 2/14/2020
ESSA Pharma Inc.: Major Shareholders
4
Wednesday, 11/20/2019
Replimune Group, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 4/3/2019
Replimune Group, Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Wednesday, 2/13/2019
Translate Bio, Inc.: Major Shareholders
SC 13D
Wednesday, 2/13/2019
ESSA Pharma Inc.: Major Shareholders
SC 13G
Wednesday, 2/13/2019
Replimune Group, Inc.: Major Shareholders
4
Wednesday, 7/25/2018
Replimune Group, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 7/19/2018
Replimune Group, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 7/3/2018
Translate Bio, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 6/27/2018
Translate Bio, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 6/25/2018
Kezar Life Sciences, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 6/20/2018
Kezar Life Sciences, Inc.: Initial statement of beneficial ownership of securities
SC 13G/A
Friday, 2/9/2018
ESSA Pharma Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2017
Egalet Corp: Major Shareholders
4
Wednesday, 6/29/2016
Paratek Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Wednesday, 2/10/2016
Egalet Corp: Major Shareholders
SC 13G
Friday, 1/22/2016
ESSA Pharma Inc.: Major Shareholders
SC 13G
Friday, 2/13/2015
Egalet Corp: Major Shareholders
3
Monday, 11/10/2014
Paratek Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 2/13/2014
Egalet Corp: Statement of changes in beneficial ownership of securities
3
Wednesday, 2/5/2014
Egalet Corp: Initial statement of beneficial ownership of securities